ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,062.00
-0.10%
다우존스 지수
40,003.59
0.34%
Bitcoin
66,952.38
0.02%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. USOTC
  6. Sorrento Therapeutics Inc (CE) (SRNEQ)

  7. Sorrento Therapeutics Inc (CE) (SRNEQ) 뉴스

SRNEQ

Sorrento Therapeutics (CE) (SRNEQ)

Sorrento Therapeutics Inc (CE)
일자:
정렬 기준:
 검색 관련기사 보기:USOTC:SRNEQ
일자시간출처헤드라인심볼기업
2023/11/0806:34Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/10/0606:26Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/10/0606:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/10/0606:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/09/2705:54Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/09/2705:49Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/09/2605:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/08/2200:20Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/08/1105:14Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/07/1906:23Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/07/0810:49Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/06/2206:25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/06/2106:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/06/1522:44Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/05/1919:04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/05/1604:18Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/05/1601:04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/05/1306:29Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/05/0919:03Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/05/0319:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/04/2106:28Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/04/2101:09Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/04/1221:51Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/04/1106:23Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/04/1104:16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/03/3119:17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/03/2108:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/03/2019:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/03/1101:22Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SRNEQSorrento Therapeutics Inc (CE)
2023/03/0904:20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SRNEQSorrento Therapeutics Inc (CE)
 검색 관련기사 보기:USOTC:SRNEQ

최근 히스토리

TSXV
SPC
SPC Nickel
LSE
SVIA
NASDAQ
FTFOX
Franklin Growth Allocati...
BIT
F17430
Vontobel Financial Produ...
AMEX
FML
ML S & P500 Mitts3/06
LBNK
MINTUSDT
Mint.club
BITMOT
915483
Bonos Tf 0% Mg25 Eur
LSE
HVNA
UNSW
MRPHETH
Morpheus.Network
COIN
WFCBTC
NYSE
SCE-G
Southern California Edis...
CSE
EX
Explorex Resources
COIN
GBTYBTC
BIT
P1QA51
BNP Paribas Issuance
AMEX
ECON
Columbia Emerging Market...
EU
9291T
9291T
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유